1. Home
  2. SONY vs SNY Comparison

SONY vs SNY Comparison

Compare SONY & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sony Group Corporation

SONY

Sony Group Corporation

HOLD

Current Price

$19.62

Market Cap

127.6B

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$41.53

Market Cap

104.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SONY
SNY
Founded
1946
1994
Country
Japan
France
Employees
112300
74846
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.6B
104.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SONY
SNY
Price
$19.62
$41.53
Analyst Decision
Hold
Buy
Analyst Count
1
5
Target Price
$22.00
$58.00
AVG Volume (30 Days)
5.7M
2.8M
Earning Date
05-13-2026
04-23-2026
Dividend Yield
5.33%
3.47%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3.49
Revenue Next Year
$3.08
$6.10
P/E Ratio
N/A
$6.14
Revenue Growth
N/A
N/A
52 Week Low
$19.47
$40.89
52 Week High
$30.34
$52.68

Technical Indicators

Market Signals
Indicator
SONY
SNY
Relative Strength Index (RSI) 34.02 36.66
Support Level N/A N/A
Resistance Level $23.23 $48.76
Average True Range (ATR) 0.36 0.66
MACD -0.25 -0.20
Stochastic Oscillator 7.32 16.21

Price Performance

Historical Comparison
SONY
SNY

About SONY Sony Group Corporation

Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is the global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with five major business segments.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: